,Month,Gross margin
0,Celgene,93.1%
1,Novo Nordisk,88.1%
2,Amgen,82.8%
3,Biogen,81.8%
4,Gilead,78.2%
5,AbbVie,76.9%
6,Eli Lilly,73.8%
7,AstraZenca,71.8%
8,Bristol-Myers Squibb,71.3%
9,Roche,70.7%
10,Pfizer,70.2%
11,Merck & Co.,69.2%
12,GlaxoSmithKline,67.9%
13,Johnson & Johnson,66.7%
14,Novartis,64.5%
15,Sanofi,60.2%
16,Endo,45.8%
17,Allergan,44.2%
18,Teva,44%
19,Mylan,38%
